SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-18-315949
Filing Date
2018-11-01
Accepted
2018-11-01 17:13:12
Documents
3
Group Members
CATALYSTA VENTURES, LLCCLAY B. THORPDOUGLAS REEDHATTERAS VENTURE AFFILIATES III, LPHATTERAS VENTURE PARTNERS I, LPHATTERAS VENTURE PARTNERS III, LPJOHN CRUMPLERKENNETH B. LEEROBERT A. INGRAMVENTURE CAPITAL MULTIPLIER FUND, LP, SERIES B

Document Format Files

Seq Description Document Type Size
1 SC 13D d641126dsc13d.htm SC 13D 193821
2 EX-99.7.01 d641126dex99701.htm EX-99.7.01 13937
3 EX-99.7.02 d641126dex99702.htm EX-99.7.02 15741
  Complete submission text file 0001193125-18-315949.txt   225604
Mailing Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355
Business Address 1 GREAT VALLEY PARKWAY SUITE 30 MALVERN PA 19355 (610) 981-6500
PhaseBio Pharmaceuticals Inc (Subject) CIK: 0001169245 (see all company filings)

IRS No.: 030375697 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90691 | Film No.: 181154746
SIC: 2834 Pharmaceutical Preparations

Mailing Address 280 S. MANGUM STREET, SUITE 350 DURHAM NC 27701
Business Address 280 S. MANGUM STREET, SUITE 350 DURHAM NC 27701 919-484-0730
Hatteras Venture Advisors III, LLC (Filed by) CIK: 0001674177 (see all company filings)

IRS No.: 204822068 | State of Incorp.: NC | Fiscal Year End: 1231
Type: SC 13D